Chongqi Tu

1.5k total citations
43 papers, 1.1k citations indexed

About

Chongqi Tu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Chongqi Tu has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 11 papers in Surgery. Recurrent topics in Chongqi Tu's work include Sarcoma Diagnosis and Treatment (13 papers), Bone Tissue Engineering Materials (6 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Chongqi Tu is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Bone Tissue Engineering Materials (6 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Chongqi Tu collaborates with scholars based in China and United States. Chongqi Tu's co-authors include Fan Tang, Li Min, Yan Tie, Xiawei Wei, Francis J. Hornicek, Xiangdong Zhu, Yong Zhou, Xingdong Zhang, Zhenfeng Duan and Xiao Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Chemical Engineering Journal.

In The Last Decade

Chongqi Tu

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chongqi Tu China 18 414 260 250 224 215 43 1.1k
Jacqui McGovern Australia 19 480 1.2× 185 0.7× 230 0.9× 89 0.4× 203 0.9× 44 1.0k
Yong Zhou China 22 437 1.1× 169 0.7× 163 0.7× 454 2.0× 557 2.6× 141 1.5k
Eun‐Jae Chung South Korea 23 279 0.7× 402 1.5× 184 0.7× 249 1.1× 715 3.3× 90 1.6k
Youcheng Yu China 22 506 1.2× 160 0.6× 491 2.0× 83 0.4× 341 1.6× 95 1.7k
Vlastimil Kulda Czechia 21 545 1.3× 157 0.6× 449 1.8× 149 0.7× 160 0.7× 50 1.4k
Henk‐Jan Prins Netherlands 20 400 1.0× 260 1.0× 372 1.5× 79 0.4× 394 1.8× 34 1.5k
Thomas Ziebart Germany 29 393 0.9× 948 3.6× 603 2.4× 139 0.6× 317 1.5× 76 2.3k
Nunzia Di Maggio Switzerland 18 528 1.3× 266 1.0× 430 1.7× 77 0.3× 320 1.5× 29 1.4k
Zhen Yang China 26 484 1.2× 97 0.4× 448 1.8× 190 0.8× 486 2.3× 65 1.7k

Countries citing papers authored by Chongqi Tu

Since Specialization
Citations

This map shows the geographic impact of Chongqi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongqi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongqi Tu more than expected).

Fields of papers citing papers by Chongqi Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongqi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongqi Tu. The network helps show where Chongqi Tu may publish in the future.

Co-authorship network of co-authors of Chongqi Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Chongqi Tu. A scholar is included among the top collaborators of Chongqi Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongqi Tu. Chongqi Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Han, et al.. (2024). Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma. Frontiers in Genetics. 15. 1519529–1519529. 1 indexed citations
2.
Wang, Yitian, et al.. (2024). Efficacy and safety of anlotinib in patients with desmoid fibromatosis: a retrospective analysis. Frontiers in Oncology. 14. 1399574–1399574.
3.
Luo, Yi, Minxun Lu, Yitian Wang, et al.. (2024). Biomimetic design and clinical application of Ti-6Al-4V lattice hemipelvis prosthesis for pelvic reconstruction. Journal of Orthopaedic Surgery and Research. 19(1). 210–210. 5 indexed citations
4.
Lu, Minxun, Yuqi Zhang, Jie Wang, et al.. (2023). Reconstruction of the proximal radius with 3D-printed personalized prosthesis after tumor resection: case series. Journal of Shoulder and Elbow Surgery. 33(3). 556–563. 2 indexed citations
5.
Wang, Yang, Minxun Lu, Qing Chang, et al.. (2022). Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma. Frontiers in Immunology. 13. 879560–879560. 5 indexed citations
6.
Yang, Wen, Fan Tang, Chongqi Tu, et al.. (2022). Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential. Cancer Letters. 547. 215887–215887. 65 indexed citations
7.
Luo, Yi, Mingyan Jiang, Jianguo Fang, et al.. (2021). Prolonged balloon occlusion of the lower abdominal aorta during pelvic or sacral tumor resection. Annals of Translational Medicine. 9(5). 416–416. 3 indexed citations
8.
Tang, Fan, Yan Tie, Yuquan Wei, Chongqi Tu, & Xiawei Wei. (2021). Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188606–188606. 26 indexed citations
9.
Tang, Fan, Yan Tie, Weiqi Hong, et al.. (2020). Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection. Annals of Surgical Oncology. 28(7). 4030–4048. 25 indexed citations
10.
Yao, Kai, Fan Tang, Min Li, Yong Zhou, & Chongqi Tu. (2019). Multifocal intraosseous hemangioma. Medicine. 98(2). e14001–e14001. 5 indexed citations
11.
Luo, Yi, Anqi Zeng, Aiping Fang, et al.. (2019). Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma. Investigational New Drugs. 37(5). 1006–1013. 16 indexed citations
12.
Wang, Yanling, Min Li, Hong Duan, et al.. (2018). [Therapeutic Effect of Uncemented Allograft-prosthetic Composite for the Reconstruction of Tumorous Bone Defect].. PubMed. 49(1). 129–132. 1 indexed citations
13.
Min, Li, Edwin Choy, Raphael E. Pollock, et al.. (2017). Autophagy as a potential target for sarcoma treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(1). 40–50. 18 indexed citations
14.
Li, Yongjiang, Kai Yao, Minxun Lu, et al.. (2017). Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. OncoTargets and Therapy. Volume 10. 5255–5261. 45 indexed citations
15.
Min, Li, Jacson Shen, Chongqi Tu, Francis J. Hornicek, & Zhenfeng Duan. (2016). The roles and implications of exosomes in sarcoma. Cancer and Metastasis Reviews. 35(3). 377–390. 37 indexed citations
16.
Shi, Rui, Juan Li, Fan Tang, Yi Luo, & Chongqi Tu. (2015). Identification and functional study of osteosarcoma metastasis marker genes. Oncology Letters. 10(3). 1848–1852. 4 indexed citations
17.
Qu, Bo, Xun Xia, Hong‐Hua Wu, Chongqi Tu, & Xian‐Ming Pan. (2014). PDGF-regulated miRNA-138 inhibits the osteogenic differentiation of mesenchymal stem cells. Biochemical and Biophysical Research Communications. 448(3). 241–247. 44 indexed citations
18.
Duan, Hong, et al.. (2009). Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors. Journal of Experimental & Clinical Cancer Research. 28(1). 45–45. 30 indexed citations
19.
Wang, Jingsheng, et al.. (2007). Serum Bone Turnover Markers in Patients with Primary Bone Tumors. Oncology. 72(5-6). 338–342. 17 indexed citations
20.
Tu, Chongqi, et al.. (2003). [Expression of multidrug resistance-associated protein 1 in osteosarcoma and its relationship with clinicopathologic characteristics].. PubMed. 34(4). 684–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026